CAP1 and atherosclerosis: rhPCSK9 treatment enhanced oxidized LDL (ox-LDL) uptake in monocytes, leading to foam cell formation, which is another important function of monocytes in atherosclerosis; however, ox-LDL uptake was reduced in CAP1-deficient monocytes (Fig. 5a).